| UniProt ID | RPAP3_HUMAN | |
|---|---|---|
| UniProt AC | Q9H6T3 | |
| Protein Name | RNA polymerase II-associated protein 3 | |
| Gene Name | RPAP3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 665 | |
| Subcellular Localization | ||
| Protein Description | Forms an interface between the RNA polymerase II enzyme and chaperone/scaffolding protein, suggesting that it is required to connect RNA polymerase II to regulators of protein complex formation.. | |
| Protein Sequence | MTSANKAIELQLQVKQNAEELQDFMRDLENWEKDIKQKDMELRRQNGVPEENLPPIRNGNFRKKKKGKAKESSKKTREENTKNRIKSYDYEAWAKLDVDRILDELDKDDSTHESLSQESESEEDGIHVDSQKALVLKEKGNKYFKQGKYDEAIDCYTKGMDADPYNPVLPTNRASAYFRLKKFAVAESDCNLAVALNRSYTKAYSRRGAARFALQKLEEAKKDYERVLELEPNNFEATNELRKISQALASKENSYPKEADIVIKSTEGERKQIEAQQNKQQAISEKDRGNGFFKEGKYERAIECYTRGIAADGANALLPANRAMAYLKIQKYEEAEKDCTQAILLDGSYSKAFARRGTARTFLGKLNEAKQDFETVLLLEPGNKQAVTELSKIKKELIEKGHWDDVFLDSTQRQNVVKPIDNPPHPGSTKPLKKVIIEETGNLIQTIDVPDSTTAAAPENNPINLANVIAATGTTSKKNSSQDDLFPTSDTPRAKVLKIEEVSDTSSLQPQASLKQDVCQSYSEKMPIEIEQKPAQFATTVLPPIPANSFQLESDFRQLKSSPDMLYQYLKQIEPSLYPKLFQKNLDPDVFNQIVKILHDFYIEKEKPLLIFEILQRLSELKRFDMAVMFMSETEKKIARALFNHIDKSGLKDSSVEELKKRYGG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MTSANKAIE ------CCCHHHHHH | 36.22 | 22814378 | |
| 15 | Ubiquitination | IELQLQVKQNAEELQ HHHHHHHHCCHHHHH | 25.52 | 32015554 | |
| 33 | Ubiquitination | RDLENWEKDIKQKDM HHHHHHHHHHHHHHH | 57.26 | 29967540 | |
| 57 | Acetylation | EENLPPIRNGNFRKK HHHCCCCCCCCHHHC | 51.26 | 19608861 | |
| 63 | Ubiquitination | IRNGNFRKKKKGKAK CCCCCHHHCCCCCCC | 65.88 | 24816145 | |
| 81 | Phosphorylation | KKTREENTKNRIKSY HHHHHHHHCHHHHHC | 32.73 | - | |
| 84 | Ubiquitination | REENTKNRIKSYDYE HHHHHCHHHHHCCHH | 38.99 | 29967540 | |
| 86 | Ubiquitination | ENTKNRIKSYDYEAW HHHCHHHHHCCHHHH | 39.46 | 29967540 | |
| 87 | Phosphorylation | NTKNRIKSYDYEAWA HHCHHHHHCCHHHHH | 22.36 | 25159151 | |
| 88 | Phosphorylation | TKNRIKSYDYEAWAK HCHHHHHCCHHHHHC | 19.97 | 28796482 | |
| 90 | Phosphorylation | NRIKSYDYEAWAKLD HHHHHCCHHHHHCCC | 10.18 | 25159151 | |
| 92 | Ubiquitination | IKSYDYEAWAKLDVD HHHCCHHHHHCCCHH | 12.80 | 29967540 | |
| 110 | Phosphorylation | DELDKDDSTHESLSQ HHHCCCCCCCHHHHC | 41.62 | 30266825 | |
| 111 | Phosphorylation | ELDKDDSTHESLSQE HHCCCCCCCHHHHCC | 36.34 | 30266825 | |
| 114 | Phosphorylation | KDDSTHESLSQESES CCCCCCHHHHCCCCC | 26.22 | 30266825 | |
| 116 | Phosphorylation | DSTHESLSQESESEE CCCCHHHHCCCCCCC | 40.98 | 22167270 | |
| 119 | Phosphorylation | HESLSQESESEEDGI CHHHHCCCCCCCCCC | 38.49 | 22167270 | |
| 120 | Ubiquitination | ESLSQESESEEDGIH HHHHCCCCCCCCCCC | 62.51 | 24816145 | |
| 121 | Phosphorylation | SLSQESESEEDGIHV HHHCCCCCCCCCCCC | 56.41 | 22167270 | |
| 130 | Phosphorylation | EDGIHVDSQKALVLK CCCCCCCCCCEEEEE | 32.27 | 30266825 | |
| 137 | Malonylation | SQKALVLKEKGNKYF CCCEEEEEECCCCHH | 50.31 | 26320211 | |
| 137 | Acetylation | SQKALVLKEKGNKYF CCCEEEEEECCCCHH | 50.31 | 25953088 | |
| 149 | Phosphorylation | KYFKQGKYDEAIDCY CHHHCCCCCHHHHHC | 26.32 | - | |
| 158 | Ubiquitination | EAIDCYTKGMDADPY HHHHHCCCCCCCCCC | 26.26 | 32015554 | |
| 160 | Sulfoxidation | IDCYTKGMDADPYNP HHHCCCCCCCCCCCC | 4.01 | 30846556 | |
| 165 | Phosphorylation | KGMDADPYNPVLPTN CCCCCCCCCCCCCCC | 32.42 | 27642862 | |
| 171 | Phosphorylation | PYNPVLPTNRASAYF CCCCCCCCCCHHHHH | 32.93 | 28555341 | |
| 177 | Phosphorylation | PTNRASAYFRLKKFA CCCCHHHHHHHCHHE | 6.17 | - | |
| 198 | Methylation | NLAVALNRSYTKAYS CHHHHCCCCCHHHHH | 31.71 | 115491535 | |
| 211 | Ubiquitination | YSRRGAARFALQKLE HHHHHHHHHHHHHHH | 19.48 | 29967540 | |
| 216 | Acetylation | AARFALQKLEEAKKD HHHHHHHHHHHHHHH | 59.73 | 19608861 | |
| 222 | Ubiquitination | QKLEEAKKDYERVLE HHHHHHHHHHHHHHH | 73.01 | 24816145 | |
| 224 | Phosphorylation | LEEAKKDYERVLELE HHHHHHHHHHHHHCC | 17.95 | - | |
| 243 | Ubiquitination | EATNELRKISQALAS HHHHHHHHHHHHHHH | 60.37 | 29967540 | |
| 251 | Ubiquitination | ISQALASKENSYPKE HHHHHHHCCCCCCCC | 56.14 | 29967540 | |
| 254 | Phosphorylation | ALASKENSYPKEADI HHHHCCCCCCCCCCE | 43.85 | 24719451 | |
| 271 | Acetylation | KSTEGERKQIEAQQN ECCHHHHHHHHHHHH | 51.86 | 19827715 | |
| 279 | Ubiquitination | QIEAQQNKQQAISEK HHHHHHHHHHHHHHH | 39.18 | 24816145 | |
| 284 | Phosphorylation | QNKQQAISEKDRGNG HHHHHHHHHHHCCCC | 41.43 | - | |
| 307 | Methylation | RAIECYTRGIAADGA HHHHHHHHCCCCCCH | 14.19 | 115491527 | |
| 326 | Phosphorylation | PANRAMAYLKIQKYE CHHHHHHHHHHHCHH | 8.74 | 20068231 | |
| 328 | Acetylation | NRAMAYLKIQKYEEA HHHHHHHHHHCHHHH | 30.34 | 25953088 | |
| 328 | Malonylation | NRAMAYLKIQKYEEA HHHHHHHHHHCHHHH | 30.34 | 26320211 | |
| 349 | Phosphorylation | AILLDGSYSKAFARR HHHHCCCHHHHHHHH | 21.51 | 28555341 | |
| 356 | Ubiquitination | YSKAFARRGTARTFL HHHHHHHHHHHHHHH | 43.30 | 32015554 | |
| 358 | Phosphorylation | KAFARRGTARTFLGK HHHHHHHHHHHHHHH | 15.91 | 22210691 | |
| 370 | Ubiquitination | LGKLNEAKQDFETVL HHHHHHHHCCCEEEE | 44.19 | 29967540 | |
| 388 | Phosphorylation | PGNKQAVTELSKIKK CCCHHHHHHHHHHHH | 33.94 | 21406692 | |
| 391 | Phosphorylation | KQAVTELSKIKKELI HHHHHHHHHHHHHHH | 26.55 | 21406692 | |
| 410 | Phosphorylation | WDDVFLDSTQRQNVV CCCCCCCCCCCCCCC | 28.69 | 21406692 | |
| 411 | Phosphorylation | DDVFLDSTQRQNVVK CCCCCCCCCCCCCCC | 27.69 | 21406692 | |
| 452 | Phosphorylation | QTIDVPDSTTAAAPE EEEECCCCCCCCCCC | 22.91 | 26074081 | |
| 453 | Phosphorylation | TIDVPDSTTAAAPEN EEECCCCCCCCCCCC | 28.03 | 26074081 | |
| 454 | Phosphorylation | IDVPDSTTAAAPENN EECCCCCCCCCCCCC | 20.46 | 26074081 | |
| 472 | Phosphorylation | LANVIAATGTTSKKN HHHHHHHHCCCCCCC | 26.49 | 26074081 | |
| 474 | Phosphorylation | NVIAATGTTSKKNSS HHHHHHCCCCCCCCC | 24.44 | 26074081 | |
| 475 | Phosphorylation | VIAATGTTSKKNSSQ HHHHHCCCCCCCCCC | 39.63 | 26074081 | |
| 476 | Phosphorylation | IAATGTTSKKNSSQD HHHHCCCCCCCCCCC | 41.28 | 26074081 | |
| 480 | Phosphorylation | GTTSKKNSSQDDLFP CCCCCCCCCCCCCCC | 37.95 | 30266825 | |
| 481 | Phosphorylation | TTSKKNSSQDDLFPT CCCCCCCCCCCCCCC | 47.20 | 29255136 | |
| 481 | Ubiquitination | TTSKKNSSQDDLFPT CCCCCCCCCCCCCCC | 47.20 | 32015554 | |
| 488 | Phosphorylation | SQDDLFPTSDTPRAK CCCCCCCCCCCCCCE | 31.72 | 30266825 | |
| 489 | Phosphorylation | QDDLFPTSDTPRAKV CCCCCCCCCCCCCEE | 39.46 | 30266825 | |
| 491 | Phosphorylation | DLFPTSDTPRAKVLK CCCCCCCCCCCEEEE | 17.91 | 30266825 | |
| 498 | Sumoylation | TPRAKVLKIEEVSDT CCCCEEEEEEEECCC | 51.57 | 28112733 | |
| 498 | Sumoylation | TPRAKVLKIEEVSDT CCCCEEEEEEEECCC | 51.57 | - | |
| 503 | Phosphorylation | VLKIEEVSDTSSLQP EEEEEEECCCCCCCC | 38.15 | 28555341 | |
| 505 | Phosphorylation | KIEEVSDTSSLQPQA EEEEECCCCCCCCCC | 16.83 | 28555341 | |
| 506 | Phosphorylation | IEEVSDTSSLQPQAS EEEECCCCCCCCCCC | 33.76 | 25627689 | |
| 507 | Phosphorylation | EEVSDTSSLQPQASL EEECCCCCCCCCCCC | 32.87 | 25627689 | |
| 513 | Phosphorylation | SSLQPQASLKQDVCQ CCCCCCCCCCHHHHH | 30.74 | 25159151 | |
| 515 | Ubiquitination | LQPQASLKQDVCQSY CCCCCCCCHHHHHHH | 41.79 | 32015554 | |
| 521 | Phosphorylation | LKQDVCQSYSEKMPI CCHHHHHHHHHCCCC | 26.04 | 25627689 | |
| 567 | Phosphorylation | KSSPDMLYQYLKQIE HCCHHHHHHHHHHHC | 6.62 | - | |
| 607 | Acetylation | DFYIEKEKPLLIFEI HHHHCCCCCCHHHHH | 52.62 | 20167786 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RPAP3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RPAP3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RPAP3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87; THR-111; SER-116;SER-119; SER-121 AND SER-481, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116; SER-119 ANDSER-121, AND MASS SPECTROMETRY. | |